• Explore /
  • Poster
  • / A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).

A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).

Abstract Poster

Authors

null

Mohammad O. Atiq

National Cancer Institute, Bethesda, MD

Mohammad O. Atiq , Marijo Bilusic , Fatima Karzai , Lisa M. Cordes , Julius Strauss , Houssein Abdul Sater , Jason Redman , Charalampos S. Floudas , James W. Hodge , Sofia Gameiro , William Douglas Figg , Jeffrey Schlom , William L. Dahut , James L. Gulley , Ravi Amrit Madan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Clinical Trial Registration Number

NCT04633252

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS5096)

DOI

10.1200/JCO.2021.39.15_suppl.TPS5096

Abstract #

TPS5096

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Fatima Karzai

First Author: Neal D. Shore

First Author: Hirotsugu Uemura

First Author: Jodi Lyn Layton